DDI's are concluded. And of course we passed marvelously! IV data will be even better than oral of course. All thats left is NDA and GONO. Not enough time ( April news and NDA 6 mths out) to be cute and trade CEMP even though IBB is over bought. It is my belief that CEMP is at the top 2 list of " a billion dollar drug" companies close to NDA for a buyout and it could be anytime but I think 8 months is more likely.
I think I finally found a profound point in one of your messages. Prabhavathi stated quite firmly she is waiting for all the data of the IV and Gono trials to get the highest premium. Some may sell thinking the buyout is far off ( if you think 8 months is far off). I see this as a huge positive that Cemp will not give this gem away on the cheap. It should have a 2 bill market cap as we speak ( higher next year). I see Cemp as being undervalued still so I am not looking to sell and buy lower. Good luck to those that think they can time the market..
LOl. Very low volume. Cemp holders are pretty tight fisted,even after a really nice run. Cemp just filled the 30 gap so maybe its back up to new highs from here. Im not big on technicals for bio stocks but Cemp is very loved in the bio world right now and I can see a fast reversal here.
Yea. I see huge pop on the new gono news. Pharma salivating to buy Soli …..even with out Gono so I see a pop to 40 when IV and Gono announced.
I had MDVN when the good news hit. It went from 50 to 90. Then a bio correction came and it went down to 65 which was absurd. Now it is up to 120. Cemp may give those a chance that missed the boat but I don't see it going much below 28 unless there is a huge market sell off..
Yup. Cemp will get a nice premium price. I can also see a bidding war for Soli. The offers up to now are probably very tempting but it is a smart move to wait. It will be a VERY nice premium deal.
I didn't see the attraction here. Anti biotics have a had a few winners lately but it is not the norm. 95% of the companies will fail. Cemp is a once in a every 25 yr opportunity that is still undervalued. Why look elsewhere?
I would not be surprised with the usual seasonal correction. Cemp could reset a bit. But as Buffett said this morning……If you have a great company you know is going to make great money in 5 yrs time,you buy it. Well……Cemp will be hitting on all cylinders in 1 yr. and most likely bought out in about 8 months so I will maybe buy my last big lot if it corrects to $28.00. Cheers
LOL. You are lucky the market is up 20% since CGIX tanked. If there is a market correction CGIX can go to 4 bucks.
I could match his success easily. The show is at 5PM. They either piggy back the big news of the day or the after hours news or they look at the " up on high volume list" and/or " down on high vol list" and the " unusual vol list". Even if they are wrong they can just tout a stock they have bought shares in and then dump them after dumb sheep retail buy shares. Real easy gig they have. My guess is if he said sell after conference,he is selling today.
Yea. Its called "fast" money so you can't slam him for his calls because he is paid to make day trade type calls. Something just dosnt sit right with me about his statement. There are 3 conf calls stacked together with pretty much the same news in all of them ( yet I always hear something new that I didn't know in each one.) So he is just trying to milk this trade. Then if there is a sell off after the conference he looks like a genius? What Ever. Where was he when Cemp was 9 bucks?
Yea. Cemp is a once a life time drug/Investment Opp. Those who know bio will get rich here.Traders and amateur bio retail investors will feel lucky with a few point gain and move on.
Prabhavathi has in the past at a couple of the latest conference calls has personally mentioned that Soli should be selling comparable units as K-Pak and probably more as K-Pak is quickly getting phased out due to resistance and Soli will treat many more indications. She also stated she wanted to be a better steward of the drug then other companies have exhibited in the past. I have been telling everyone for a couple of yrs now that the analysts just didn't get Soli. I don't know how they deserve the pay they get. They didn't and most still don't see how huge this drug will be. They are now raising numbers again but they are just 1 yr estimates. They will have to raise them again….by a lot ….and soon. Cemp is a $100 PPS company. Cheers
Like clockwork. Bio almost always go down on their earnings day even though no earnings are expected. Its odd and as you can see today Cemp is down even though IBB is up nicely. I think its a heavy short daily trade that the market just accepts. Cemp is a bit over bought….but what isn't?
After the trial results Soli is not considered in the "pipeline". It is considered an approved drug so to speak. And the 3 other indications in trials for Soli ( pediatrics etc.) are almost a slam-dunk. COPD,Nash,others can be considered a "pipeline" for Soli. Anyone with concerns that CEMP is a 1 drug company should move on as they can't see the forest thru the trees. Cheers